8-K
Current Report
Denali Therapeutics Inc. Filed Acc 0001714899-21-000007
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading dnli-20210108.htm…